Screener
IDEX IEX Health & Science Technologies — Measurement period adjustments
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by IDEX in its filing.
Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.
The source filing: IDEX’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:35 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000832101-26-000022
| Line item | HST | FMT | FSDP | IDEX |
|---|---|---|---|---|
| Goodwill | $2,406.5 | $801.7 | $406.9 | $3,615.1 |
| Accumulated goodwill impairment losses | (149.8) | (20.7) | (30.1) | (200.6) |
| Balance at January 1, 2026 | 2,256.7 | 781.0 | 376.8 | 3,414.5 |
| Foreign currency translation | (24.1) | (4.3) | (4.1) | (32.5) |
| Measurement period adjustments | 0.6 | — | — | 0.6 |
| Balance at June 30, 2026 | $2,233.2 | $776.7 | $372.7 | $3,382.6 |
Item 1. Financial Statements
FAQ
- What is IDEX's health & science technologies — measurement period adjustments?
- IDEX (IEX) reported health & science technologies — measurement period adjustments of $400K in Q2 2026.
- How has IDEX's health & science technologies — measurement period adjustments changed year-over-year?
- IDEX's health & science technologies — measurement period adjustments decreased by 90.0% year-over-year, from $4M to $400K.
- What does health & science technologies — measurement period adjustments mean?
- Represents adjustments made to the fair value of assets acquired or liabilities assumed during the measurement period following an acquisition. These adjustments reflect new information obtained about facts and circumstances that existed as of the acquisition date.
Ask your AI about IDEX's health & science technologies — measurement period adjustments.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude